<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Best Practices in Drug and Biological Product Postmarket Safety Surveillance for Food and Drug Administration Staff; Draft Document; Availability; Establishment of Public Docket; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Best Practices in Drug and Biological Product Postmarket Safety Surveillance for Food and Drug Administration Staff; Draft Document; Availability; Establishment of Public Docket; Request for Comments</h1>
    <p class="timestamp">Published: 2019-11-07 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is establishing a public docket to collect comments on a draft document that details best practices for drug safety surveillance entitled "Best Practices in Drug and Biological Product Postmarket Safety Surveillance for FDA Staff." The 21st Century Cures Act (Cures Act) was enacted on December 13, 2016, and requires that FDA make publicly available on its internet website best practices for drug safety surveillance activities. The draft document s...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2019-24332</p>
    <p><strong>Publication Date:</strong> 2019-11-07</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2019/11/07/2019-24332/best-practices-in-drug-and-biological-product-postmarket-safety-surveillance-for-food-and-drug">https://www.federalregister.gov/documents/2019/11/07/2019-24332/best-practices-in-drug-and-biological-product-postmarket-safety-surveillance-for-food-and-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2019-24332</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
